Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer death, partly due to the high recurrence rates for patients with PDAC. Current postoperative surveillance methods, including monitoring of clinical symptoms, tumor markers, and CT imaging, lack sensitivity and specificity...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jiahong, Ye, Song, Xu, Yaping, Chang, Lianpeng, Hu, Xiaoge, Ru, Guoqing, Guo, Yang, Yi, Xin, Yang, Liu, Huang, Dongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406781/
https://www.ncbi.nlm.nih.gov/pubmed/32850360
http://dx.doi.org/10.3389/fonc.2020.01220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406781/
https://www.ncbi.nlm.nih.gov/pubmed/32850360
http://dx.doi.org/10.3389/fonc.2020.01220

Ejemplares similares